Pharmafile Logo
Pharmafocus logo
Advanced Search

Shire

Showing 15 posts of 170 posts found.

takeda_deerfield_hq

Takeda plans to vacate all 1,000 staff from US HQ by the year’s end

June 26, 2019
Manufacturing and Production, Medical Communications, Sales and Marketing Shire, Takeda, US, pharma

Takeda has announced its plans to vacate all staff from its US headquarters in Deerfield, Illinois, by the end of …

News
novartis_window

Novartis buys dry eye treatment Xiidra in deal worth $5.3 billion

May 9, 2019
Business Services, Medical Communications, Sales and Marketing Novartis, Shire, Takeda, debt, pharma, xiidra

Japanese multinational Takeda Pharmaceutical has agreed to sell its dry eye drug Xiidra to Swiss firm Novartis in a deal …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

January 11, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Bristol-Myers Squibb, Shire, Takeda, bristol myers squibb, death row, pharma, top 10

With the completion of Takeda’s £46 billion acquisition of Shire finally done, another even bigger merger was announced as US …

News
takeda_global_hq

Takeda completes Shire acquisition

January 8, 2019
Manufacturing and Production M&A, MA, Shire, Takeda, acquisition, deal, pharma

Japanese firm Takeda Pharmaceuticals has successfully completed its acquisition of Shire Plc. The long anticipated deal has propelled the firm …

News

Takeda shareholders approve $62bn Shire acquisition

December 6, 2018
Business Services Ireland, Japan, M&A, MA, Shire, Takeda, acquisition

Japanese firm Takeda have gained shareholders’ approval for the $62 billion acquisition of the Irish headquartered company Shire Plc. The …

News
shire_image

Shire’s Takhzyro scores EU approval in rare genetic disorder hereditary angioedema

December 3, 2018
Sales and Marketing EU, Europe, Shire, Takhzyro, pharma

Shire has announced that it has secured European approval for its subcutaneous injection Takhzyro (lanadelumab) for the routine prevention of …

News

Takeda set to move from Deerfield Illinois, 1000 jobs affected

September 12, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jobs, Shire, Takeda, deerfield, illinois

Japanese multinational Takeda is set to shut down its US headquarters in Deerfield, Illinois following the final stages of its …

News
shire_image

Shire hands over its oncology franchise to Servier for $2.4bn

August 31, 2018
Medical Communications, Sales and Marketing Cancer, Servier, Shire, oncology, pharma, sale

Shire has completed the sale of its oncology franchise to French firm Servier for $2.4 billion, handing over the global …

News
takeda_usa_pharmaceuticals_u

Takeda to sell Osaka site to soften Shire deal’s financial impact

July 5, 2018
Manufacturing and Production, Sales and Marketing Japan, Osaka, Shire, Takeda, acquisition, pharma

It’s one of the biggest acquisitions the industry has seen at a total value of $63 billion and after weeks …

News
canada_block_001_takeda

Takeda shareholders try to buck Shire deal

June 11, 2018
Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical

A small group of Takeda shareholders have started making a lot of noise over its $62 billion deal for Shire, …

News
roche

Roche’s Hemlibra stakes claim to be haemophilia market leader

May 21, 2018
Research and Development, Sales and Marketing Hemlibra, Roche, Shire, biotech, drugs, haemophilia, pharma, pharmaceutical

Hemlibra was widely expected to become the dominant therapeutic for treating haemophilia patients and its latest clinical trial results only …

News

Takeda financials show why the Shire deal was needed

May 14, 2018
Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical

After posting its financials from 2017 and its guidance for the year to come, it’s clear to see why Takeda …

News
top_ten

Top Ten most popular articles on Pharmafile.com this week

May 11, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, EMA, GSK, J&J, JJ, Novartis, Shire, Takeda, Valeant, biotech, drugs, pharma, pharmaceutical

It’s been a week in which one of the largest pharmaceutical takeovers in history took place and yet it’s not …

News
takeda_global_hq

It’s official: Takeda to buy Shire for £46 billion

May 8, 2018
Manufacturing and Production, Sales and Marketing Shire, Takeda, acquisition, pharma

After more than a month of uncertainty, Takeda has finally confirmed it has managed to successfully acquire Shire, agreeing on …

News
top_ten

Top Ten most popular articles on Pharmafile.com this week

May 4, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, EMA, Kymriah, Novartis, Porton Biopharma, Regeneron, Roche, Sandoz, Sanofi, Shire, Takeda, biosimilars, dementia

It’s Friday again and it’s been a week busy with companies’ financials. One company’s in particular were of note due …

News

Latest content

BactiVac funds development of bacterial vaccines to prevent infections against antimicrobial resistance

September 28, 2023

Avalyn Pharma raises $175m in Series C financing for inhalation therapies

September 28, 2023

NMD Pharma begins phase 2 trial for spinal muscular atrophy treatment

September 27, 2023

Alfasigma to acquire Intercept Pharmaceuticals for $19 per share

September 27, 2023

Regeneron and Sanofi’s sBLA for Dupixent accepted by FDA for priority review

September 26, 2023